A retrospective analysis of the safety and efficacy of lokivetmab for the treatment of canine atopic dermatitis at the QMHA from September 2017 to May 2020
(Elective)
XX(44437.2)
1 available
Description
Copies
| Location | Call Number | Status |
|---|---|---|
| Online Resources - Online Resources | XX(44437.2) | On Shelf |
Citations
Gustafson, L. E. A retrospective analysis of the safety and efficacy of lokivetmab for the treatment of canine atopic dermatitis at the QMHA from September 2017 to May 2020.
Chicago / Turabian - Author Date Citation, 18th Edition (Style Guide)Gustafson, Laura Elizabeth. A Retrospective Analysis of the Safety and Efficacy of Lokivetmab for the Treatment of Canine Atopic Dermatitis At the QMHA From September 2017 to May 2020.
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 18th Edition (Style Guide)Gustafson, Laura Elizabeth. A Retrospective Analysis of the Safety and Efficacy of Lokivetmab for the Treatment of Canine Atopic Dermatitis At the QMHA From September 2017 to May 2020. .
UCL Harvard Citation (Style Guide)Gustafson, L. E. (n.d.). A retrospective analysis of the safety and efficacy of lokivetmab for the treatment of canine atopic dermatitis at the QMHA from september 2017 to may 2020.
MLA Citation, 9th Edition (Style Guide)Gustafson, Laura Elizabeth. A Retrospective Analysis of the Safety and Efficacy of Lokivetmab for the Treatment of Canine Atopic Dermatitis At the QMHA From September 2017 to May 2020.